Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$63.15 - $72.88 $71.3 Million - $82.3 Million
-1,128,634 Reduced 32.15%
2,381,505 $163 Million
Q1 2024

May 15, 2024

BUY
$71.58 - $87.29 $251 Million - $306 Million
3,510,139 New
3,510,139 $257 Million
Q3 2023

Nov 14, 2023

SELL
$73.94 - $80.67 $4.7 Million - $5.13 Million
-63,575 Reduced 32.4%
132,674 $9.94 Million
Q2 2023

Aug 14, 2023

SELL
$76.01 - $86.7 $405,437 - $462,457
-5,334 Reduced 2.65%
196,249 $15.1 Million
Q1 2023

May 15, 2023

SELL
$77.31 - $88.08 $8.85 Million - $10.1 Million
-114,475 Reduced 36.22%
201,583 $16.7 Million
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $19.7 Million - $28.3 Million
316,058 New
316,058 $27.1 Million
Q1 2022

May 16, 2022

SELL
$57.92 - $72.58 $3.66 Million - $4.59 Million
-63,243 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$64.88 - $73.64 $4.1 Million - $4.66 Million
63,243 New
63,243 $4.59 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $26 Million - $29.7 Million
-459,519 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$62.1 - $78.08 $28.5 Million - $35.9 Million
459,519 New
459,519 $29 Million
Q1 2020

May 15, 2020

SELL
$62.63 - $80.22 $4.42 Million - $5.66 Million
-70,586 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$61.62 - $67.78 $4.35 Million - $4.78 Million
70,586 New
70,586 $4.59 Million
Q3 2019

Nov 14, 2019

SELL
$62.51 - $69.0 $25 Million - $27.6 Million
-399,775 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $55,002 - $61,678
-889 Reduced 0.22%
399,775 $27 Million
Q1 2019

May 15, 2019

BUY
$62.53 - $70.05 $25.1 Million - $28.1 Million
400,664 New
400,664 $26 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $115B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Voloridge Investment Management, LLC Portfolio

Follow Voloridge Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.